Evidence-Based Medicine Guidelines
Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dabigatran Versus LMWHs for Thromboprophylaxis After Total Hip or Knee Replacement." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457030/all/Dabigatran_versus_LMWHs_for_thromboprophylaxis_after_total_hip_or_knee_replacement.
Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457030/all/Dabigatran_versus_LMWHs_for_thromboprophylaxis_after_total_hip_or_knee_replacement. Accessed October 14, 2024.
Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457030/all/Dabigatran_versus_LMWHs_for_thromboprophylaxis_after_total_hip_or_knee_replacement
Dabigatran Versus LMWHs for Thromboprophylaxis After Total Hip or Knee Replacement [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457030/all/Dabigatran_versus_LMWHs_for_thromboprophylaxis_after_total_hip_or_knee_replacement.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
ID - 457030
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457030/all/Dabigatran_versus_LMWHs_for_thromboprophylaxis_after_total_hip_or_knee_replacement
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
